Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers

NCT00743912 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic

Interventions

DRUG: rifaximin

Sponsor

Bausch Health Americas, Inc.